These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11522275)

  • 1. Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity.
    Rosset J; Wang J; Wolfe BM; Dolphin PJ; Hegele RA
    Clin Biochem; 2001 Jul; 34(5):381-6. PubMed ID: 11522275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
    Carlson LA; Holmquist L; Assmann G
    Acta Med Scand; 1987; 222(4):345-50. PubMed ID: 3425387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique genetic and biochemical presentation of fish-eye disease.
    Kuivenhoven JA; van Voorst tot Voorst EJ; Wiebusch H; Marcovina SM; Funke H; Assmann G; Pritchard PH; Kastelein JJ
    J Clin Invest; 1995 Dec; 96(6):2783-91. PubMed ID: 8675648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
    Bruckert E; von Eckardstein A; Funke H; Beucler I; Wiebusch H; Turpin G; Assmann G
    Atherosclerosis; 1997 Jan; 128(1):121-8. PubMed ID: 9051205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
    J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited disorders of HDL metabolism and atherosclerosis.
    Hovingh GK; de Groot E; van der Steeg W; Boekholdt SM; Hutten BA; Kuivenhoven JA; Kastelein JJ
    Curr Opin Lipidol; 2005 Apr; 16(2):139-45. PubMed ID: 15767853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
    Marcil M; Boucher B; Krimbou L; Solymoss BC; Davignon J; Frohlich J; Genest J
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1015-24. PubMed ID: 7627690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease).
    Pritchard PH; McLeod R; Frohlich J; Park MC; Kudchodkar BJ; Lacko AG
    Biochim Biophys Acta; 1988 Feb; 958(2):227-34. PubMed ID: 3122840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia.
    Martín-Campos JM; Julve J; Escolà JC; Ordóñez-Llanos J; Gómez J; Binimelis J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2002 Jan; 43(1):115-23. PubMed ID: 11792730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma.
    Cheung MC; Wang DB; Lum KD; Albers JJ
    Biochim Biophys Acta; 1988 Sep; 962(2):258-64. PubMed ID: 3139041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-drug interaction: additive influence of mutant APOA1 and testosterone on plasma HDL-cholesterol.
    Keyhan G; Rosset J; Wang J; Miller D; McManus R; Hegele RA
    Clin Biochem; 2002 Jul; 35(5):341-6. PubMed ID: 12270762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes.
    Pisciotta L; Calabresi L; Lupattelli G; Siepi D; Mannarino MR; Moleri E; Bellocchio A; Cantafora A; Tarugi P; Calandra S; Bertolini S
    Atherosclerosis; 2005 Sep; 182(1):153-9. PubMed ID: 16115486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.